My ePortfolio Register   

Review of prostate cancer at EMCC 2011

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.10.11
Views: 2418

Dr Karim Fizazi - Institut Gustave Roussy, France

Dr Karim Fizazi highlights the news on prostate cancer at the European Multidisciplinary Cancer Conference in Stockholm. The top news highlights how in the past ten years on two major developments have occurred in castration resistant prostate cancer; however, five new drugs, chemotherapies and now the information on alpha particles have been unveiled.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence